90 related articles for article (PubMed ID: 8964331)
1. [The binding of 3H-spiperone to lymphocytes in patients with schizophrenia and first-degree relatives: in search of a genetic marker].
Heinze G; King GB; Huerto L; Ortega H; Cortés J; Ariza JR
Gac Med Mex; 1994; 130(4):241-5. PubMed ID: 8964331
[TBL] [Abstract][Full Text] [Related]
2. [Association between uptake to lymphocytes from schizophrenic patients and therapeutic efficacy].
Shimogawa S; Kaku H; Yoshimoto S; Nakane Y
Yakubutsu Seishin Kodo; 1986 Jun; 6(2):239-46. PubMed ID: 2877529
[TBL] [Abstract][Full Text] [Related]
3. Alteration of dopamine receptors in the caudate nucleus and the putamen in schizophrenic brain.
Mjörndal T; Winblad B
Med Biol; 1986; 64(6):351-4. PubMed ID: 2881030
[TBL] [Abstract][Full Text] [Related]
4. Abnormal neuroleptic/dopamine receptors in schizophrenia.
Lee T; Seeman P
Adv Biochem Psychopharmacol; 1980; 21():435-42. PubMed ID: 6103653
[TBL] [Abstract][Full Text] [Related]
5. 3H-spiperone binding sites in lymphocytes as possible vulnerability marker in schizophrenia.
Bondy B; Ackenheil M
J Psychiatr Res; 1987; 21(4):521-9. PubMed ID: 3481637
[TBL] [Abstract][Full Text] [Related]
6. Abnormal glucocorticoid dependent increase of spiperone binding sites on lymphocytes from schizophrenics in vitro.
Halbach M; Henning U
Pharmacopsychiatry; 1989 Sep; 22(5):169-73. PubMed ID: 2813506
[TBL] [Abstract][Full Text] [Related]
7. The sequestration of [3H]spiperone by lymphocytes in schizophrenics and their first-degree relatives: a limited vulnerability marker?
Griffiths RS; Chung-a-on KO; Griffiths KD; Payne JW; Davies JI
J Psychiatr Res; 1992 Jan; 26(1):77-84. PubMed ID: 1560411
[TBL] [Abstract][Full Text] [Related]
8. 3H-spiperone binding to lymphocytes in neuroleptic-naive-schizophrenia and the effect of neuroleptic treatment.
Laufer N; Spivak B; Holdengreber V; Zipser J; Kosower N; Ragolsky M; Weizman A
Clin Neuropharmacol; 1999; 22(2):110-4. PubMed ID: 10202608
[TBL] [Abstract][Full Text] [Related]
9. Preliminary studies of human cortical 5-HT2 receptors and their involvement in schizophrenia and neuroleptic drug action.
Reynolds GP; Rossor MN; Iversen LL
J Neural Transm Suppl; 1983; 18():273-7. PubMed ID: 6135746
[TBL] [Abstract][Full Text] [Related]
10. Binding of 3H-spiperone to human lymphocytes: a biological marker in schizophrenia?
Bondy B; Ackenheil M; Elbers R; Fröhler M
Psychiatry Res; 1985 May; 15(1):41-8. PubMed ID: 2409568
[TBL] [Abstract][Full Text] [Related]
11. [Catecholaminergic receptors of the blood cells of schizophrenics].
Ackenheil M; Bondy B; Fröhler M; Vakis A
Encephale; 1985; 11(3):95-100. PubMed ID: 2992909
[TBL] [Abstract][Full Text] [Related]
12. Catecholamines and their receptors in blood: evidence for alterations in schizophrenia.
Bondy B; Ackenheil M; Birzle W; Elbers R; Fröhler M
Biol Psychiatry; 1984 Oct; 19(10):1377-93. PubMed ID: 6097309
[TBL] [Abstract][Full Text] [Related]
13. 3H-spiperone binding capacity in mononuclear cells: a family study.
Bondy B; Ackenheil M; Ertl M; Minelli G; Mundt C; Peuker B; Schleuning G; Sauer H
Prog Neuropsychopharmacol Biol Psychiatry; 1993 May; 17(3):373-81. PubMed ID: 8475319
[TBL] [Abstract][Full Text] [Related]
14. 3H-spiperone binding sites in post-mortem brains from schizophrenic patients: relationship to neuroleptic drug treatment, abnormal movements, and positive symptoms.
Kornhuber J; Riederer P; Reynolds GP; Beckmann H; Jellinger K; Gabriel E
J Neural Transm; 1989; 75(1):1-10. PubMed ID: 2563750
[TBL] [Abstract][Full Text] [Related]
15. [3H]spiroperidol binding on lymphocytes: changes in two different groups of schizophrenic patients and effect of neuroleptic treatment.
Le Fur G; Zarifian E; Phan T; Cuche H; Flamier A; Bouchami F; Burgevin MC; Loo H; Gérard A; Uzan A
Life Sci; 1983 Jan; 32(3):249-55. PubMed ID: 6130459
[TBL] [Abstract][Full Text] [Related]
16. [P50 component of auditory evoked potentials in persons with schizophrenia and their first degree relatives].
Wegrzyn J; Wciórka J
Psychiatr Pol; 2004; 38(3):395-408. PubMed ID: 15199650
[TBL] [Abstract][Full Text] [Related]
17. Measurement of dopamine D2-like receptors in postmortem CNS and pituitary: differential regional changes in schizophrenia.
Dean B; Pavey G; Scarr E; Goeringer K; Copolov DL
Life Sci; 2004 May; 74(25):3115-31. PubMed ID: 15081577
[TBL] [Abstract][Full Text] [Related]
18. Glutamate receptors in the postmortem striatum of schizophrenic, suicide, and control brains.
Noga JT; Hyde TM; Herman MM; Spurney CF; Bigelow LB; Weinberger DR; Kleinman JE
Synapse; 1997 Nov; 27(3):168-76. PubMed ID: 9329152
[TBL] [Abstract][Full Text] [Related]
19. Early visual sensory deficits as endophenotypes for schizophrenia: high-density electrical mapping in clinically unaffected first-degree relatives.
Yeap S; Kelly SP; Sehatpour P; Magno E; Javitt DC; Garavan H; Thakore JH; Foxe JJ
Arch Gen Psychiatry; 2006 Nov; 63(11):1180-8. PubMed ID: 17088498
[TBL] [Abstract][Full Text] [Related]
20. 3H-spiperone binding to peripheral mononuclear cells in psychiatric in-patients.
Wodarz N; Fritze J; Riederer P
Prog Neuropsychopharmacol Biol Psychiatry; 1996 Apr; 20(3):459-70. PubMed ID: 8771601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
